![Pushkal Garg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pushkal Garg
Teknisk/Vetenskaplig/F&U Direktör på
ALNYLAM PHARMACEUTICALS, INC.
Förmögenhet: 6 M $ per 2026-06-30
Profil
Pushkal P.
Garg is currently an Independent Director at SQZ Biotechnologies Co. since 2018.
Dr. Garg is also EVP, Chief Research & Development Officer at Alnylam Pharmaceuticals, Inc. starting in 2025.
Formerly, Dr. Garg was Vice President-Global Clinical Research at Bristol Myers Squibb Co. Education includes undergraduate studies at the University of California, Berkeley and a doctorate from The University of California, San Francisco.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-05 | 19 374 ( 0,01 % ) | 6 M $ | 2026-06-30 |
Aktiva positioner av Pushkal Garg
| Företag | Position | Start |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2014-10-29 |
| SQZ BIOTECHNOLOGIES COMPANY | Direktör/Styrelseledamot | 2018-08-01 |
Tidigare kända positioner av Pushkal Garg
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | - |
Pushkal Gargs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
